Last month, the DEA designated Hexahydrocannabinol (HHC) as a Schedule I controlled substance and assigned it a unique drug code.

Since then, lawsuits have been filed challenging the DEA's rulemaking in both the Fourth and Ninth Circuits.

But while the courts are still sorting things out, something else is already happening: Banks and payment processors are making decisions.

Across the country, hemp businesses are reporting that merchant processors are warning them to remove HHC products, or risk losing access to credit card processing altogether.

In this video, Attorney Morgan Davis discusses:

The DEA's HHC scheduling decision
The lawsuits challenging the rulemaking
Why payment processors are reacting now
The business risks of continuing to sell HHC products
What hemp retailers and manufacturers should expect next

Whether you manufacture, distribute, or sell hemp products, understanding what is happening with HHC right now is critical.

Because sometimes the market reacts long before the law is settled.

+++++++++

THIS VIDEO IS MEANT TO ASSIST IN A GENERAL UNDERSTANDING OF THE CURRENT LAW AND PRACTICE RELATING TO THE TOPICS DISCUSSED. IT IS NOT TO BE REGARDED AS LEGAL ADVICE. COMPANIES OR INDIVIDUALS WITH PARTICULAR QUESTIONS SHOULD SEEK THE ADVICE OF COUNSEL.